We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Provexis Plc | PXS | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.60 | 09:34:30 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.60 | 0.60 |
| Industry Sector |
|---|
| FOOD PRODUCERS |
| Top Posts |
|---|
Posted at 31/10/2023 18:51 by redprince Informer - thank you for taking the time to both attend and feed back to the rest of us who did not attend.I have been to x 3 pxs agm's and the SIS meeting and its quite expensive for me as i live far away so i do appreciate your attendance and feedback.Much of what you reorted makes sense apart from the absence of doubling up in our accounts although that may show later? My biggest concern is the prospect of a 75% majority agreeing to a take out once By-Health get going.For all i know Stuart Lucas could get behind that and after 14+ years and a substantial stake here i dont want to get taken out on the cheap!! Anyway i am hoping to have some funds available in the new year and if everything works out i am willing to buy more so that i can live with whatever happens.Still think there is going to be plenty of time before By-Health get the SAMR completed. Thanks again. |
Posted at 30/10/2023 20:48 by winner31 Thanks informer . DSM customers stocking up before the transfer makes sense , looking forward their stocks won’t last that long , so they’ll soon be reordering from pxs . The more I read about DSM the more it seems they were throwing their toys out of the pram when pxs broke away , makes you wonder if their plan was to buy- out pxs on the cheap and IF has thrown a spanner in their works . Hopefully we can grow sales from now on with new customers , and when Byhealth launch their products a bid would be very welcome . Also good news that dilution probably not going to happen ! |
Posted at 30/10/2023 20:01 by informer Re: Provexis AGM 2023Although the ideal opportunity to hold IF to account I am pretty sure nobody here managed to attend. I do believe that most of you live some way from London and especially in the light of the largely negative sentiment and rightly so - especially by those who have held the longest - may have found the trip difficult to justify. It seemed that shareholders who did attend entered the room sharing exactly the same negativity. However with the exception of the De-Rampers for RedPrince, Gixer, Winner, Bareknee etc there were one or two interesting points which may offer just a bit of encouragement. Whilst IF acknowledged that figures to March 31st were uninspiring and in particular DSM Sales it was stated that most customers had been encouraged prior to December 31st to double up on order quantities resulting in PXS inheriting an overstocked customer base. He confirmed that he was committed to increasing Shareholder value and that he was currently in discussion with a number of third parties to progress new sales and distribution opportunities for Fruitflow and that independent sales teams have been incentivised in this respect. He confirmed that despite numerous requests DSM had been unable to provide him with any sales forecasts going forward. IF re-iterated that in the 6 months following year end Sales of Fruitflow II SD ingredient in excess of £280k and confirmed Sales Orders in excess of £155k were currently being processed and that the company is dealing with numerous enquiries from both new and existing customers. There appeared a genuine positivity in this respect and hope we can look forward to positive Interims come December. It was explained that IF had insisted on payment up front from all DSM customers which had been accepted in every case thus adding no additional pressure on Cash Flow. He also stated that as DSM stocks of Fruitflow were of no use to anyone else he felt he was in the driving seat and negotiations were ongoing bearing in mind best before dates etc etc. IF intimated that future business would be self funding and that he would only consider share dilution as a last resort. R&D costs were questioned - we have an amazing product - the science is good why are we not spending on Sales as opposed to R&D - it was explained that most of the R&D costs relate to maintaining Patents and that the cost of each goes up annually. It was felt that the value of the company is equal to the value of its Patents. Clearly all are pinning hopes on By Health and encouraged that no sooner had the new SAMR Implementation Rules been published By Health the very next day made its application for Fruitflow approval as a new permitted health function to maintain normal platelet aggregation. Apparently Felix is working in China on a British Passport obtained with the help from Provexis - no idea about this one. Finally after the meeting had finished there seemed a genuine air of positivity with the talk of takeover in the new year as the main source of conversation. Also Stuart Lucas is not a stupid man why would he feel the need to add to his holding - perhaps he knows something you don't ? E&OE This is not word for word and apologies if I have missed out or misinterpreted anything - don't shoot the messenger - take it for what it is. |
Posted at 01/9/2023 21:18 by redprince I am going in the middle wrt timescale here.It would probably take a >= 1 year if the pre submission work had not been as thorough but given the work that By-Health have done and that they have been working steadfastly toward this end i believe we are looking at 6 months to under a year.Once again this week we saw folks grasping at straws after the somewhat ambiguous rns trying to interpret it as tens of millions USD.We knew from before that originally the sum was in the ballpark of £1 million so with the extra trials that has grown to £2 million not tens of million gbp. What we dont know is the likelihood and quantum of extra funding that may be needed. Anyway it is good to know that the submission is underway at long last. Clearly By-Health are very keen on FF but again we have no idea what our margin is likely to be. My gut tells me it is likely to be several years before we can ascertain the scope of the deal with any real clarity - time for sales to build and profit to accrue to pxs. Not withstanding a price spike on news of product launch i suspect a lot of pi's will look to bail "early" and the price is likely to be volatile until it all settles down and revenues become more predictable. Hard to believe it has taken this long! |
Posted at 29/8/2023 07:38 by gix er Raymond John McKeeve was/is his name. Doubt he holds any shares in PXS anymore. Ocado might have been something to do with that. |
Posted at 11/8/2023 15:39 by nestoframpers I reckon if anything good should happen to PXS ( yawn ) they will spike the share price to get LTHs to get out once they are not under water ( we will be so grateful) , then it will slowly fall and then, out of the blue ....... |
Posted at 11/8/2023 14:30 by nestoframpers ReWe are an r&d co with no experience in sales or crm. Surely our CEO has been in the seat long enough to have learnt everything he needs to know to get PXS noticed . He'd have done better with a sandwich board walking around London than he has. |
Posted at 24/5/2023 16:28 by winner31 The present revenue has little relevance to pxs going forward , and if the board have prioritised the By-health contract for these others then maybe we can get the revenue growing a lot quicker than from the likes of H&B , to be honest h&b have not pushed this product once in the 5 years since the contract started , I go into H&b quite a lot and ff+ has never been in your face when you walk in even in the early days , so good riddance if the contract is over , we have much bigger fish to fry imho. |
Posted at 24/5/2023 07:18 by gix er BB, I agree that not being able to supply customers is bad news but there is no evidence that would suggest that the above products being out of stock is anything to do with the lack of FF being supplied by Provexis or DSM.Yes there could have been a delay due to the company signing contracts with Healthspan and Simply Supplements but there could also be various other reasons. Both Healthspan and Simply say there products are manufactured in the UK (possibly the same manufacturer)and there could be an issue with them. We don't even know if these companies are direct customers of Provexis and may be waiting on DSM to supply the premix. Not the first time products have been out of stock for a long time when DSM were in charge. Swanson FF (now gone) springs to mind. Holland and Barrett is a different situation and we know Fruitflow Plus is a DSM market ready solutions product (could be a premix but doubt it) so if stock is low then you could blame pxs/dsm but, and I hope I am wrong, I think the Holland and Barrett relationship has come to an end. So Yes it could have been an issue with the hand over or long lead times with DSM supplying premixes/market ready solutions but it could easily be something else altogether. "balls up" possibly, but not necessarily ours or DSM's. 2 new products came to market very recently and it looks like PXS could have supplied the FF for them. |
Posted at 23/5/2023 22:11 by bareknee Nearly the end of May, so not far off being five months into being responsible for supplying Fruitflow to customers and a quick check shows :-Simply Supplements ( Blood Pressure Formula ) out of stock ( and have been a while ) Holland Barrett out of stock of FF+ ( not sure how long for ) Healthspan out of stock ( Circulease ) on their website, expected to be back in stock in August. Provexis have, I presume, stock ( doesn't say otherwise on the website ) Circulease from Healthspan is in stock on Amazon though, as is FF+ from PXS via Amazon. Granted, some teething problems on taking over the distribution were to be expected, but it is currently looking like a balls up, not necessarily by Ford, he could have been let down by DSM, but not being able to supply regular customers, however small, isn't a great start. Obviously, if you wanted to be 100% positive about the situation you could argue that our FF stock has been low because ByHealth have got first dabs on it, which may even be correct, but it's not a good look. BB |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
